These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7825635)

  • 21. 5 alpha-reductase-catalyzed conversion of testosterone to dihydrotestosterone is increased in prostatic adenocarcinoma cells: suppression by 15-lipoxygenase metabolites of gamma-linolenic and eicosapentaenoic acids.
    Pham H; Ziboh VA
    J Steroid Biochem Mol Biol; 2002 Nov; 82(4-5):393-400. PubMed ID: 12589947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and hormonal effects of the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism.
    Moghetti P; Castello R; Magnani CM; Tosi F; Negri C; Armanini D; Bellotti G; Muggeo M
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1115-21. PubMed ID: 7962284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological options for treatment of hyperandrogenic disorders.
    Reismann P; Likó I; Igaz P; Patócs A; Rácz K
    Mini Rev Med Chem; 2009 Aug; 9(9):1113-26. PubMed ID: 19689407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
    Horton R; Hawks D; Lobo R
    J Clin Invest; 1982 May; 69(5):1203-6. PubMed ID: 7068855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
    Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM
    Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polycystic ovarian disease: the adrenal connection.
    Marouliss GB; Triantafillidis IK
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():205-7. PubMed ID: 16641861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase.
    Wright AS; Douglas RC; Thomas LN; Lazier CB; Rittmaster RS
    Endocrinology; 1999 Oct; 140(10):4509-15. PubMed ID: 10499505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostatic growth: new insights into hormonal regulation.
    McConnell JD
    Br J Urol; 1995 Jul; 76 Suppl 1():5-10. PubMed ID: 7544215
    [No Abstract]   [Full Text] [Related]  

  • 29. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.
    Klus GT; Nakamura J; Li JS; Ling YZ; Son C; Kemppainen JA; Wilson EM; Brodie AM
    Cancer Res; 1996 Nov; 56(21):4956-64. PubMed ID: 8895750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostates, pates, and pimples. The potential medical uses of steroid 5 alpha-reductase inhibitors.
    Tenover JS
    Endocrinol Metab Clin North Am; 1991 Dec; 20(4):893-909. PubMed ID: 1723383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of oral contraceptives in the treatment of hyperandrogenic disorders.
    Burkman RT
    Am J Med; 1995 Jan; 98(1A):130S-136S. PubMed ID: 7825633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum androsterone conjugates differentiate between acne and hirsutism in hyperandrogenic women.
    Carmina E; Stanczyk FZ; Matteri RK; Lobo RA
    Fertil Steril; 1991 May; 55(5):872-6. PubMed ID: 1827073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen sulfate and glucuronide conjugates in nonhirsute and hirsute women with polycystic ovarian syndrome.
    Matteri RK; Stanczyk FZ; Gentzschein EE; Delgado C; Lobo RA
    Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1704-9. PubMed ID: 2532471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of some novel inhibitors of C17,20-lyase and 5alpha-reductase in vitro and in vivo and their potential role in the treatment of prostate cancer.
    Nnane IP; Kato K; Liu Y; Lu Q; Wang X; Ling YZ; Brodie A
    Cancer Res; 1998 Sep; 58(17):3826-32. PubMed ID: 9731491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome.
    Fassnacht M; Schlenz N; Schneider SB; Wudy SA; Allolio B; Arlt W
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2760-6. PubMed ID: 12788885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of hirsutism with 5 alpha-reductase inhibitors.
    Brooks JR
    Clin Endocrinol Metab; 1986 May; 15(2):391-405. PubMed ID: 3521959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of dicyclohexane derivatives on androgen metabolism in the rat prostate.
    Sirett DA; Quivy JI; Foret D; Jacquemyns CF; Rousseau GG
    J Steroid Biochem; 1985 Oct; 23(4):497-501. PubMed ID: 3865028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased 5 alpha-reductase activity in idiopathic hirsutism.
    Serafini P; Lobo RA
    Fertil Steril; 1985 Jan; 43(1):74-8. PubMed ID: 3155511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen excess: Investigations and management.
    Lizneva D; Gavrilova-Jordan L; Walker W; Azziz R
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():98-118. PubMed ID: 27387253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correlations between clinical signs and hormonal parameters in young women with hirsutism].
    Kristesashvili J; Chanukvadze D
    Georgian Med News; 2011 Nov; 11(200):30-5. PubMed ID: 22201077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.